Diabetes technologies represent a paradigm shift in type 1 diabetes care. Continuous
subcutaneous insulin infusion (CSII) pumps and continuous glucose monitors (CGM) …

Many studies have clearly established that chronic psychosocial stress may sustainably
worsen glycemic control in patients with type 1 diabetes mellitus (T1DMM), thus promoting …

Consumer wearable technology use is widespread and there is a need to validate measures
obtained in uncontrolled settings. Because no standard exists for the treatment of heart rate …

In the field of blood glucose prediction, the literature is abounded with algorithms that
demonstrate potential in glucose management. However, these propositions face an issue …

The development of continuous glucose monitoring (CGM) systems has enabled people
with type 1 diabetes mellitus (T1DM) to track their glucose trajectory in real-time and inspired …

In Type 1 diabetes patients, even ultra-rapid acting insulins injected subcutaneously reach
peak concentrations in 45 minutes or longer. The lag time between dosing and peak …

The way a drug molecule is administered has always had a profound impact on people
requiring medical interventions-from vaccine development to cancer therapeutics. In the …

Algorithm-enabled patient prioritization and remote patient monitoring (RPM) have been
used to improve clinical workflows at Stanford and have been associated with improved …

Diabetes management datasets are often compiled from various sensors and devices,
including diabetes technology, activity trackers, and other health-related equipment …

This paper presents a control strategy for blood glucose regulation in the presence of an
unknown time-varying delayed input. The proposed control scheme is based on an observer …